RenJi Hospital: Urinary Bladder Neoplasms trials

The registry lists 11 Urinary Bladder Neoplasms studies with RenJi Hospital as lead sponsor. 8 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 6Phase 3 1Phase 4 1No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Trop2-targeted immunoPET Imaging of Solid TumorsRecruitingNCT06851663Phase 2/3
• The Efficacy of Gallium[68Ga]NOTA-DNA Multivalent SGC8 Injection for Bladder Tumour ImagingRecruitingNCT06763354Not applicable
• Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder CarcinomaRecruitingNCT06091124Phase 2
• [68Ga] NOTA-SGC8 in the Staging of Bladder CancerRecruitingNCT06005116Not applicable
• RC48 Combined With Toripalimab and Radiotherapy for Bladder Sparing Treatment in MIBCRecruitingNCT05979740Phase 2
• RC48 Combined With Tislelizumab for Bladder Sparing Treatment in NMIBC With BCG Treatment Failure and HER2 ExpressionRecruitingNCT05957757Phase 2
• Influence of Anesthesia Methods on CTCs in TURBT PatientsNot yet recruitingNCT05824299Not applicable
• Bladder Sparing Treatment of Tislelizumab, Gemcitabine and Cisplatin for Patients With PD-L1 Positive Muscle Invasive Bladder CancerRecruitingNCT05401279Phase 2
• Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly PatientsStatus unknownNCT05068180Phase 4
• Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients (TACBIN-01)Status unknownNCT04922047Phase 1/2
• Circulatory Function in Laparoscopic Radical Cystectomy for Bladder CancerCompletedNCT03892031